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A B S T R A C T   
Introduction: Reduction of the maternal mortality ratio (MMR) to 12 per 100,000 live births by 2030 is a priority 
target in Georgia. This study aims to assess and classify MM in Georgia by direct and indirect causes of death 
from 2014 to 2017, using data from the national surveillance system and in accordance with internationally 
approved criteria. 
Material and methods: In this secondary study, MM data was retrieved from the Maternal and Children’s Health 
Coordinating Committee and validated with data from the Vital Registry System and the Georgian Birth Registry. 
The study sample comprised 61 eligible MM cases. Relevant information was transferred to case-report forms to 
review and classify MM cases by direct and indirect causes of maternal death. 
Results: The MMR during the study period was 26.7 per 100,000 live births. The proportion of direct causes of 
maternal death exceeded that of indirect causes, at 62% and 38%, respectively. The leading direct cause of 
maternal death was haemorrhage, while infection was the most frequent indirect cause. 52.5% of MM cases had 
no pre-existing medical condition, 62.3% had frequent adherence to antenatal care, and 52.5% had emergency 
caesarean sections. 
Conclusion: In Georgia, direct causes of maternal death exceed indirect causes in MM cases, with haemorrhage 
and infections, respectively, being most common. These findings are important to ensure optimal and continuous 
care and to accelerate progress in the reduction of MM in the country.   
Introduction 
Maternal mortality ratio (MMR) is an important indicator of 
maternal health and perinatal care. Although significant progress has 
been made in the past decade [1–2], the global reduction of MMR re-
mains a critical challenge. Following the United Nation’s Millennium 
Development Goals by 2015, maternal health was also prioritised in the 
Sustainable Development Goals, with the target to reduce MMR below 
70 per 100,000 livebirths by 2030 [2–3]. Recent studies of maternal 
mortality (MM) have demonstrated that 94% of all maternal deaths 
occur in the developing world [4]. According to the WHO, the MMR in 
low-income countries was 239 per 100,000 live births compared to 12 in 
the rest of the world in 2015 [5–8]. Direct obstetric causes account for 
about 86% of all maternal deaths globally, with haemorrhage being the 
most common cause [7]. However, most MM cases are preventable, and 
about 50% of cases are avoidable [9,10]. In order to reach the desired 
reduction in MMR, efforts must focus on the improvement of all parts of 
the continuum of reproductive healthcare, accurate surveillance, and 
understanding the causes of maternal death [2,9,10]. 
Over the last decade, Georgia, a developing lower-middle-income 
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country with a population of 3,719,300 [11], has embraced evidence- 
based medicine and implemented a health improvement programme 
with the aim of bettering the quality of health care. State expenses for 
healthcare increased 2.5 times since 2012, and these expenses currently 
claim 3.7% of the country’s gross domestic product. In 2013, Georgia 
launched its Universal Health Care Programme, which entitles every 
citizen to a basic package of health services and is a visible demon-
stration of the country’s commitment to the Sustainable Development 
Goals. Perinatal services are integrated into this programme, including 
antenatal care (ANC). According to official statistics, from 2006 to 2016, 
the MMR fluctuated between 32.1 and 23 per 100,000 live births 
[11,12,13]. The health improvement programme also sought to imple-
ment relevant policy to improve perinatal health and develop national 
surveillance, reporting, and registration systems and to reduce the MMR 
to 12 per 100,000 live births by 2030 [13,14]. 
The Maternal and Children’s Health Coordinating Committee 
(MCHCC), part of the Ministry of Internally Displaced Persons from the 
Occupied Territories, Labour, Health, and Social Affairs of Georgia 
(MoH), receives notification of each maternal death within 24 h of its 
occurrence. Reporting of all medical information related to these 
maternal deaths is also mandatory. The MCHCC is responsible for a 
national surveillance and response system based on Confidential En-
quiries into Maternal Deaths. This entails active tracking and systematic 
multidisciplinary investigation of all maternal deaths occurring in 
Georgia, followed by a response that aims to avoid future maternal 
deaths and improve maternal health care [15,16,17]. In 2012, Georgia 
implemented the WHO case-report form for death registration and 
classification. In addition, under the administration of the National 
Centre for Disease Control and Public Health (NCDC), the country 
created the Georgian Birth Registry (GBR), enhanced Vital Registry 
System (VRS), improved follow-up of maternal deaths through the 
Electronic Integrated Disease Surveillance System, and implemented the 
verbal autopsy methodology as part of the surveillance of MM. More-
over, specific guidelines, clinical protocols, and tailored courses for the 
management of common causes of maternal death were created and 
provided to medical personnel. Details of the surveillance of MM 
introduced by the MoH and the reporting and registration supported by 
the NCDC are described elsewhere [13,18]. 
So far, little attention has been given to surveillance system-based 
studies. There are few studies that scrutinise persistent causes of MM 
in developing countries like Georgia, where there are a shortage of 
appropriate epidemiological reports based on reliable data. No study has 
yet employed data from the Georgian surveillance system to evaluate 
whether this data can be used by stakeholders to direct efforts to 
improve maternal healthcare and thus accelerate progress toward the 
reduction of MMR in Georgia. Therefore, this study aims is to assess and 
classify MM in Georgia by direct and indirect causes of death from 2014 
to 2017, using data from the national surveillance system and in 
accordance with internationally approved criteria. 
Materials and methods 
We defined maternal death according the International Statistical 
Classification of Diseases and Related Health Problems, Tenth Revision 
(ICD-10), i.e., the death of a woman while pregnant or within 42 days of 
delivery or termination of pregnancy through any causes associated 
with, or exacerbated by, pregnancy or its management; it did not include 
deaths from incidental or accidental causes [19]. 
This study utilised secondary data provided by the MCHCC. All MM 
cases reported to the MCHCC for the years 2014 through 2017 were 
collected, reviewed, and validated by the study authors during 2018. 
The final study sample comprised 61 eligible MM cases, which were 
registered officially in Georgia as MM cases during the same time period. 
Causes of maternal death were classified as direct (obstetric com-
plications of the pregnant state or its management) or indirect (resulting 
from a previous existing disease or a disease that developed during 
pregnancy, and which were not due to a direct obstetric cause), and 
categorised by ICD-10 code [19]. If both direct and indirect causes of 
death were recorded, and the starting mechanism for the chain of events 
was determined to be obstetric, the case was classified as having a direct 
cause of maternal death. Suicide (n = 2) was not included as a direct 
cause of death in this analysis, contrary to the recommended practice of 
the ICD-MM [20]. Indeed, ICD-MM recommended practice is not yet 
accepted worldwide, and Georgia currently follows ICD-10 classifica-
tions. Therefore, suicide was defined as an indirect cause of maternal 
death, following the ICD-10 classification of this term, excluding mental 
and behavioural disorders associated with the puerperium from direct 
cause of death. Final diagnoses were validated with autopsy records 
when available. 
Relevant information from MCHCC medical documents was trans-
ferred to a standardised case-report form, which was designed for this 
particular study. The form synthesised data on demographic charac-
teristics, health, perinatal conditions, and other diagnoses (recorded by 
ICD-10 code) in order to fully ascertain the cascade of events leading to 
maternal death and establish diagnoses independent of the MCHCC 
decision. In MM cases with insufficient information in the MCHCC, VRS, 
and GBR, demographic or obstetric data were acquired from additional 
NCDC sources (Electronic Integrated Disease Surveillance System; ver-
bal autopsy). 
The MMR for the study period was defined as the number of eligible 
MM cases per 100,000 live births. The confidence interval (CI) was 
estimated as a Wald Interval. All analyses were performed using STATA 
15 (StataCorp LLC, College Station, TX, USA). In analyses of direct and 
indirect causes of maternal death, MM cases that occurred outside of 
medical facilities with no autopsy or verbal autopsy could not be clas-
sified and were excluded. 
Ethical consideration 
The Institutional Review Board of NCDC approved the legal aspects 
of the study (IRB #2017-009). In addition, regional Committees for 
Medical and Health Research Ethics (REC North) approved the protocol 
(Ref: 2017/404/REK nord). Personal identification remained hidden to 
the investigator at all times and the data are free from personal 
identifiers. 
Results 
Over the 4-year study period (2014–2017), there were 228,300 live 
births in Georgia [11] with an MMR of 26.7 per 100,000 live births. All 
MM cases reported to the MCHCC during the study period (n = 84) were 
identified (including incidental, accidental, and late maternal deaths), 
reviewed, and validated against MM cases in the GBR and VRS using the 
unique personal identification number assigned to Georgian residents/ 
citizens. Pregnancy-related ICD-10 codes (O00-O95 and 98-99, A34, 
B20-B24, C58, X60-X84) were used for additional validation of MM 
cases or identification of possible misclassified MM cases in both regis-
tries [19], but this process did not reveal any additional MM cases for 
this period in Georgia. Following the maternal death definition in the 
ICD-10, and after validation in the VRS and GBR, 23 MM cases were 
excluded by the study authors (12 due to late maternal death, 9 due to 
accidental death, and 2 due to occurrence in occupied territories in 
Georgia with lack of information). Thus, 61 eligible MM cases comprised 
the study sample (Table 1). The majority of MM cases were 25–34 years 
old (44.3%), married (77%), and lived in rural areas (55.7%). Medical 
facilities could not be classified by the level of provided services (pri-
mary, secondary, and tertiary) during the study period, as this classifi-
cation was only completed after 2017 in Georgia. A large proportion of 
MM cases were multiparous (49.9%), had no pre-existing medical con-
ditions (52.5%), and had low-risk pregnancies (73.8%). Moreover, 
62.3% of MM cases adhered to obligatory ANC, 42.6% had preterm 
deliveries (between 22 and 36 weeks of gestation), and 52.5% had an 
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emergency caesarean section (CS) (Table 2). 
Thirty-six (62%) MM cases were due to direct causes of maternal 
death, and 22 were due to indirect causes (38%). Three MM cases were 
unclassifiable, as the death occurred outside medical facilities with 
limited medical data. Due to this issue, these cases were excluded from 
the further analysis. Two of the unclassifiable cases died during 
pregnancy, and one in the late postpartum period. When considering 
direct causes of maternal death, three MM cases (8.3%) died from 
anaesthetic complications, two during childbirth, and one 7–42 days 
postpartum after oesophageal haemorrhage and sepsis caused by a 
misplaced tube during intubation. Two deaths (5.5%) were related to 
ectopic pregnancies, three to amniotic fluid embolism (8%), and six to 
venous thromboses (18%). Four MM cases (11.1%) were attributed to 
eclampsia and the haemolysis, elevated liver enzymes, and a low platelet 
count (HELLP) syndrome (Table 3). 
Among all direct causes, haemorrhage was the “initiating” event in 
the cascade of complications, which represented 29.5% (95% CI: 
19.4–41.9) of all MM cases in our study. Nine MM cases died within 24 
h, six died 2–6 days postpartum, and three died 7–42 days postpartum. 
Nine of these 18 cases had neither severe maternal diseases nor any 
severe pregnancy-related conditions. Fourteen of these cases had CS and 
died from postpartum bleeding. Seven of those 14 had no serious 
maternal- or pregnancy-related diseases recorded in their medical file. 
Only one MM case was attributed to uterine rupture, whereas six cases 
experienced placental abruption. Extensive blood loss was reported in 
seven MM cases (≥1500 ml); blood transfusion was provided in 11 cases 
(Table 4). 
Hysterectomy was performed in 13 MM cases, among whom nine 
ended up with disseminated intravascular coagulation. Post-caesarean 
laparotomy was performed in five cases that suffered haemorrhage, 
but none of these cases received uterine artery embolisation as an 
alternative treatment. Pre-eclampsia was the dominant pregnancy- 
related disease associated with haemorrhage, mainly in combination 
with severe obesity and emergency CS. Moreover, severe obesity was 
observed in five out of 18 haemorrhage cases, anaesthesia complications 
in two of three, venous thromboembolism in four of six, and ectopic 
pregnancy one of two MM cases (Tables 3 and 4). 
Of all 22 MM cases attributed to indirect causes of maternal death, 
seven died during pregnancy, three died 2–6 days postpartum, and 12 
died 7–42 days postpartum (Table 5). The leading cause of indirect 
maternal death was infection (10 cases, comprising 45.5%); among 
them were leptospirosis (2 cases), pneumonia (2 cases), tuberculosis (2 
cases), meningitis (2 cases), and hepatitis (1 case). Three became 
pregnant after a cancer diagnosis (acute leukaemia) and two had a 
diagnosis of malformations. Of those, four died during pregnancy and 
the fifth a few days after childbirth. Three MM cases died from com-
plications of cardiovascular disease, three from suicide, and one case 
from complications due to a cholecystectomy in the postpartum period 
(Table 5). 
Thirty-one percent of MM cases had incomplete medical records, i.e., 
missing ANC related data, autopsy data, and histology reports. 
Discussion 
This is the first study of MM that has been performed after the cre-
ation of the MCHCC in Georgia. We found that the share of direct causes 
of maternal death exceeded that of indirect causes of maternal death. 
Haemorrhage was the leading direct cause of maternal death, and 
infection was the most common indirect cause. The estimated MMR 
during our study period was 26.7 per 100,000 live births. This number 
confirms the relatively stable MMR reported by the country’s official 
national statistics office for the last decade [11,13]. Moreover, it reflects 
the same level of MM recently reported from middle-income countries in 
Europe (Romania, Russian Federation, and Turkey), Central and East 
Asia (Armenia, Azerbaijan, Turkmenistan, and Uzbekistan), and Latin 
America (Costa Rica) [7,10,21,22,23]. However, the observed MMR in 
Georgia is double that of most high-income countries [1,24,25] and far 
from the ratio being targeted for 2030 in Georgia [13,14]. Obviously, 
some actions have already been taken to change the current MMR; 
although, tailored solutions based on evidence should be initiated to 
reach the desired goal before the deadline. 
A notable finding was the proportion of direct and indirect causes of 
Table 1 
Selection of maternal mortality cases. Georgia, 2014–2017.   
2014 2015 2016 2017 Total 
Total cases 26 24 17 17 84  
Excluded cases 
Late maternal death 5 3 1 3  
Accidental death – 1 4 4  
De facto territories – – 1 1   
Final study sample 21 20 11 9 61  
Table 2 
Demographic and prenatal characteristics associated with 
maternal mortality. Georgia, 2014–2017.   
Total n = 61  
n (%) 
Age groups 
18–24 14 (22.9) 
25–34 27 (44.3) 
35–47 19 (31.2) 
Unknownb 1 (1.6)  
Marital status 
Married 47 (77) 
Never married 9 (14.75) 
Unknown 5 (8.25)  
Parity 
Primiparous 27 (44.3) 
Multiparous 30 (49.4) 
Missingc 4 (6.6)  
Residency 
Rural 34 (55.7) 
Urban 27 (44.3)  
Pre-existing medical condition 
Yes 15 (24.6) 
No 32 (52.5) 
Unknown 14 (22.9)  
Adherence to antenatal care 
No care 6 (9.8) 
1–4 28 (45.9) 
>4 10 (16.4) 
Missing 17 (27.9)  
High-risk pregnancy 
Yes 16 (26.2) 
No 45 (73.8)  
Gestational age 
≤22 weeks 5 (8.2) 
Preterm (22–36 weeks) 26 (42.6) 
Early term (37–38 weeks) 10 (16.4) 
Full term (39–40 weeks) 12 (19.7) 
Late term (41–42 weeks) 3 (4.9) 
Unknown 5 (8.2)  
Mode of delivery 
Normal vaginal 15 (24.6) 
Planed CSa 3 (4.9) 
Emergency CSa 32 (52.5) 
Died during pregnancy 11 (18)  
a Caesarean section. 
b Supporting medical document or data was lacking in the data 
source. 
c Empty box or insufficient information in the respective data 
source. 
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maternal death (62% and 38%, respectively). It is important to analyse 
the distribution of these causes, as it gives an indication of the quality of 
antenatal, perinatal, postpartum, and continuum of care. When direct 
causes of maternal death exceed indirect causes, it suggests that ob-
stetric care is substandard [26]. The study of global causes of maternal 
death and other retrospective studies have shown results similar to ours 
in other developing countries, where direct causes of maternal death 
account for around 70% of MM [5,22]. The proportions we report differ 
from the previous Georgian study, in which direct causes of maternal 
deaths accounted for 77% of MM cases and indirect causes accounted for 
23% [18]. Our results indicate that Georgia is making progress in 
decreasing the MMR due to direct causes of maternal death; however, 
some aspects still need attention. The notably low number of high-risk 
pregnancies and co-morbidities we observed in MM cases are another 
indicator of substandard care, especially on an ANC level. Timely 
recognition of complications is important for correct diagnosis and 
treatment, which are important if MM is to be prevented [10,27]. To 
accelerate progress in the prevention of MM, Georgia should enhance 
optimal obstetric care, improve ANC guidelines to detect high-risk 
pregnancies and co-morbidities, and ensure that midwives and 
Table 3 
Direct causes of maternal death - major maternal, pregnancy, and delivery related events, excluding haemorrhage. Georgia, 2014–2017.  
Time of death Maternal condition Pregnancy-related condition Mode of delivery Delivery-related condition Postpartum events 
In pregnancy Obesity Ectopic pregnancy Not applicable Not applicable Not applicable 
In pregnancy None Ectopic pregnancy Not applicable Not applicable Not applicable 
Delivery None Preeclampsia Emergency CSb Anaesthesia complications Not applicable 
Delivery Obesity None Emergency CSb Anaesthesia complications Not applicable 
7–42 days Obesity Preeclampsia Emergency CSb Anaesthesia complications Oesophageal haemorrhage, sepsis 
1st 24 h None None Emergency CSb Amniotic fluid embolism Hysterectomy 
1st 24 h None Preeclampsia Emergency CSb Amniotic fluid embolism None 
2–6 days Anaemia None Vaginal Amniotic fluid embolism HELLPa, DICc 
1st 24 h None None Vaginal None Venous thromboembolism 
2–6 days Obesity None Emergency CSb None Venous thromboembolism 
2–6 days Obesity None Emergency CSb None Venous thromboembolism 
7–42 days Obesity Preeclampsia Emergency CSb None Venous thromboembolism 
7–42 days Obesity None Planned CSb None Venous thromboembolism 
7–42 days None None Emergency CSb None Venous thromboembolism 
1st 24 h None Preeclampsia Vaginal Eclampsia None 
7–42 days None Eclampsia Emergency CSb None HUSd, hysterectomy, DICc 
7–42 days None HELLPa Vaginal Haemorrhage Septic shock 
7–42 days None HELLPa Vaginal None Septic shock  
a Haemolysis, elevated liver enzymes, and a low platelet count. 
b Caesarean section. 
c Disseminated intravascular coagulation. 
d Haemolytic-Uremic Syndrome. 
Table 4 





Pregnancy-related condition Mode of 
delivery 
Delivery-related condition Blood loss 
(ml) 
Postpartum events 
1st 24 h None None Emergency CSa Haemorrhage 1300b Hysterectomy 
1st 24 h None None Emergency CSa Haemorrhage Unknown Hysterectomy, DICc 
1st 24 h None None Emergency CSa Haemorrhage, uterine rupture Unknownb None 
1st 24 h None None Vaginal Haemorrhage, deep laceration 2500b Laparotomy 
1st 24 h None Preeclampsia Emergency CSa Haemorrhage, atony Unknown Hysterectomy, DICc 
1st 24 h None Preeclampsia /eclampsia Vaginal Haemorrhage 1800b Hysterectomy 
1st 24 h Obesity Preeclampsia Emergency CSa Haemorrhage, abrubtio 
placenta 
1200b Hysterectomy, DIC 
1st 24 h Obesity Cervical cerclage, 
preeclampsia 
Emergency CSa Haemorrhage 600 None 
1st 24 h Obesity Placenta praevia Emergency CSa Haemorrhage, abrubtio 
placenta 
2200b Hysterectomy 
2–6 days None None Emergency CSa Haemorrhage, abrubtio 
placenta 
2000b DICc 
2–6 days None None Emergency CSa Haemorrhage, atony 2100b Hysterectomy, DICc 
2–6 days None None Vaginal Haemorrhage, deep laceration Unknownb Hysterectomy, DICc 
2–6 days None None Emergency CSa Haemorrhage, atony 800 None 
2–6 days Obesity None Emergency CSa Haemorrhage, abrubtio 
placenta 
3500a Hysterectomy, DICc 
2–6 days Obesity Preeclampsia Emergency CSa Haemorrhage, abrubtio 
placenta 
2500a Hysterectomy, DICc 
7–42 days None None Vaginal Retained products Unknownb Haemorrhage, hysterectomy 
7–42 days None Preeclampsia Planned CSa None Unknownb HELLPd, haemorrhage, 
hysterectomy 
7–42 days Anaemia Preeclampsia Emergency CSa Haemorrhage, abrubtio 
placenta 
Unknown Haemorrhage, hysterectomy  
a Caesarean section. 
b Blood transfusion. 
c Disseminated intravascular coagulation. 
d Haemolysis, elevated liver enzymes, and a low platelet count. 
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obstetricians complete special courses within the framework of their 
Continuous Medical Education. These measures could lower the pro-
portion of MM due to direct causes of maternal death, and hence 
decrease the MMR. 
Haemorrhage was the foremost direct cause of maternal death in our 
study. The latest study of global causes of maternal death showed that 
haemorrhage accounted for 27.1% of MM cases and represented the 
leading cause of maternal death worldwide [7]. In the present study, 
maternal death due to haemorrhage represented 29.5% of all MM cases, 
which is a common number in countries with a similar socio- 
development index [5]. Our findings correspond to previous informa-
tion about leading causes of maternal death in Georgia, which also cited 
haemorrhage as the most common cause of death [13,18]. The majority 
of these cases occurred in low-risk pregnancies with no severe 
pregnancy-related conditions. However, the main mode of childbirth for 
these cases was emergency CS, and the indication for CS was lacking. 
Indeed, CS has intrinsic risks that can lead to a cascade of complications 
in both non-risk and high-risk pregnancies [28]. Therefore, the high 
fatality rate in these cases suggests inappropriate indications for CS, 
poor diagnostic skills, and lack of follow-up by responsible medical 
personnel during the post-operative period, which indicates necessity 
for future studies. Our results also suggest that there is a lack of active 
management in the third stage of labour to prevent haemorrhage, and 
that artery embolization is under-used as an alternative treatment for 
haemorrhage [28]. In general, haemorrhage is a preventable cause of 
maternal death, and recent studies have outlined ways to optimise the 
outcome of this condition. These publications promote a multidisci-
plinary team approach and the application of checklist-based protocols 
for the timely management of haemorrhage [13,28], neither of which 
was evidenced in our data. Additionally, the volume of blood lost or 
other justifications for such treatment did not consistently accompany 
reports of blood transfusion in our study. Nonetheless, study findings on 
haemorrhage are an additional indication of substandard care at all 
levels of reproductive services, including the inappropriate evaluation of 
risks, justification for blood transfusion, detection of co-morbidities, and 
lack of knowledge-based performance during obstetric emergencies. In 
order to further reduce the MMR, is it important to equip medical 
personnel with current knowledge and approaches to managing life- 
threatening conditions. These steps must be taken if we are to improve 
the quality of medical care for pregnant women and prevent haemor-
rhage as a major direct cause of maternal death. 
Our study identified infection as the leading cause of indirect 
maternal death. Contrary to national improvements in access to anti-
biotic treatment, preventive vaccination, and advanced diagnostic and 
laboratory services, our results show a noticeably high proportion of MM 
attributable to infections [13,18]. Thus it may be possible to prevent 
mortality through more appropriate clinical solutions. However, our 
results lead us to believe that there is a fragmentation in continuous 
obstetric care, low quality of ANC, a lack of either continuous care or 
communication with sub specialists, and weak multidisciplinary ap-
proaches, all of which suggest substandard care. In their study of bar-
riers to accessing adequate maternal care in Georgia, Miteniece et al. 
also indicated substandard care, along with gaps in clinical quality and 
staff skills, poor communication, and lack of continuous education 
programmes in the Georgian health care system [29]. After all, if a 
country is looking to accelerate its progress in preventing maternal 
death, it is not sufficient to improve ANC coverage; it is also necessary to 
ensure high quality and continuous care. Better medical performance 
and updated guidelines for provided services are needed, along with 
improved collaboration with specialists and timely referrals 
[10,15,23,30]. 
The major strength of this paper is the use of data from the MCHCC, 
along with validation from and enrichment with register-based data. In 
MM studies, Confidential Enquiries into Maternal Deaths and registries 
give researchers a great advantage, as they allow them to obtain infor-
mation, analyse non-aggregated and consistence data, validate cases, 
and understand the full cascade of events [10,27]. Some of the limita-
tions of this study include the primary data source, which was hospital 
records. Because of this, some problems arose in deciphering hand-
writing. Additionally, 31% of our MM cases had medical records with 
incomplete or missing information, which could have led to under-
reporting; thus our results should be interpreted with caution. Moreover, 
our results showed that autopsy and forensic service are infrequent in 
Georgia, which is not unique, as many other developing countries face a 
Table 5 
Indirect causes of maternal death - major maternal, pregnancy and delivery related events. Georgia 2014–17.  
Time of death Maternal condition Pregnancy-related condition Mode of delivery Delivery-related 
condition 
Postpartum events 
In pregnancy Acute leukaemia None Not applicable Not applicable Not applicable 
In pregnancy Ovarian cancer None Not applicable Not applicable Not applicable 
In pregnancy Cerebral malformation None Not applicable Not applicable Not applicable 
2–6 days Acute leukaemia None Emergency CSc None Cachexia 
7–42 days Cerebral malformation None Emergency CSc None Cerebral haemorrhage 
In pregnancy None Pneumonia Not applicable Not applicable Not applicable 
In pregnancy None Leptospirosis, pneumonia, sepsis Not applicable Not applicable Not applicable 
In pregnancy None Leptospirosis, chorioamnionitis, 
sepsis 
Not applicable Not applicable Not applicable 
2–6 days Multi resistant TBa None Vaginal None Acute respiratory distress 
2–6 days None TB, preeclampsia Emergency CSc None Acute respiratory distress 
7–42 days None Pneumonia Emergency CSc None Acute respiratory distress 
7–42 days None Pneumonia Emergency CSc None Acute respiratory distress 
7–42 days None None Vaginal None Meningitis 
7–42 days None None Unknown None Bacterial meningitis 
7–42 days Chronic hepatitis None Emergency CSc None Acute liver failure, sepsis 
7–42 days None None Emergency CSc None Complicated cholecystitis 
7–42 days CVDb None Emergency CSc None Cardiomyopathy 
7–42 days CVDb None Emergency CSc None Severe cardiac failure 
7–42 days Cardiomyopathy None Vaginal None Severe cardiac failure 
In pregnancy Mental disorder, suicide None Not applicable Not applicable Not applicable 
7–42 days None None Planned CSc None Mental disease, suicide 
7–42 days None None Vaginal Retained products Haemorrhage, sepsis, hysterectomy, 
suicide  
a Tuberculosis. 
b Cardiovascular disease. 
c Caesarean section. 
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similar problem, especially for ANC [31,32]. However, given the 
importance of decreasing the MMR, it is vital to have detailed, quality 
information on this topic [25]. Under the circumstances, insufficient 
medical files cannot guarantee a high-quality enquiry using MCHCC 
data. Indeed, this insufficiency led to the exclusion of 3 unclassifiable 
cases from our analyses as well. Furthermore, in-depth future studies on 
the quality of reproductive healthcare should address some specific 
questions (e.g. skills and competencies of medical personnel, quality of 
care at any level, provision and access to family planning, high pro-
portion of CS and consistent of their indications). Limitation of the 
present study includes a small study sample with low MM in absolute 
numbers. Thus, results cannot fully address failure of reproductive 
healthcare system in specific health-related conditions (tuberculosis, 
hepatitis, and leukaemia). However, provided results are important to 
prioritize methodology for future studies and enhance them with the 
“near-miss” approach - identification and additional assessment of cases 
in which pregnant women survive certain complications [2,16]. 
Overall, our findings indicate the challenges Georgia faces in accel-
erating the reduction of MM. This evaluation of the causes of MM and 
classification of cases by direct and indirect causes of death with the use 
of national surveillance data may be used to generate new recommen-
dations for clinical practice and policy improvement. This study has 
important implications for the quality enhancement of reproductive 
healthcare in Georgia. The present findings indicate the existence of 
weaknesses and gaps in the healthcare system that can only be improved 
through the collaboration of different stakeholders. Regular and sys-
tematic analyses, transparency, and involvement of professional asso-
ciations, main decision makers, and healthcare authorities will 
strengthen reproductive healthcare and accelerate Georgia’s progress to 
decrease MM. Moreover, austerity measures should be considered to 
ensure optimal obstetric care and family planning, to launch country-
wide Continuous Medical Education for obstetricians, and to tailor 
trainings for midwives to tackle the knowledge gap. Measures should 
also be taken to trigger timely treatment or referral for multidisciplinary 
care and the establishment of routine autopsies in MM cases should be 
considered. 
Conclusion 
In Georgia, contrary to high-income countries, direct causes of death 
exceed indirect causes of death in MM cases, with haemorrhage and 
infections, respectively, being most common. The results suggest 
increasing efforts toward decreasing the MMR, where high-quality MM- 
related medical data and data completeness applications are crucial to 
obtain best medical measures and policies. The study findings are 
important to guide stakeholders and ensure that they implement 
optimal, continuous care and effective follow-up, and to accelerate 
progress in the reduction of MM in the country. 
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